NeuBase Therapeutics Inc (NBSE)
0.378
0.00 (0.00%)
USD |
NASDAQ |
May 17, 16:00
NeuBase Therapeutics Price to Free Cash Flow
Price to Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Free Cash Flow Data
| Date | Value |
|---|---|
| April 17, 2006 | -- |
| April 13, 2006 | -- |
| April 11, 2006 | -- |
| April 10, 2006 | -- |
| March 31, 2006 | -- |
| March 13, 2006 | -- |
| March 03, 2006 | -- |
| February 01, 2006 | -- |
| December 31, 2005 | -- |
| October 31, 2005 | -- |
| October 24, 2005 | -- |
| September 30, 2005 | -- |
| August 31, 2005 | -- |
| July 29, 2005 | -- |
| July 05, 2005 | -- |
| June 30, 2005 | -- |
| June 10, 2005 | -- |
| Date | Value |
|---|---|
| June 09, 2005 | -- |
| June 02, 2005 | -- |
| May 09, 2005 | -- |
| May 03, 2005 | -- |
| April 28, 2005 | -- |
| April 18, 2005 | -- |
| March 31, 2005 | -- |
| March 29, 2005 | -- |
| February 14, 2005 | -- |
| February 11, 2005 | -- |
| January 24, 2005 | -- |
| January 20, 2005 | -- |
| January 19, 2005 | -- |
| January 18, 2005 | -- |
| January 13, 2005 | -- |
| January 11, 2005 | -- |
| December 31, 2004 | -- |
Price to Cash Flow Definition
Price to free cash flow measures the Price / TTM Free Cash Flow. Like other price ratios (ie. PE Ratio, PS Ratio, P/B Ratio), this metric can be used to compare companies with similar capital structures. Free cash flow gives an idea of how much cash is available for shareholders through stock buybacks and dividend payouts. A lower price to free cash flow is more desirable when assessing different companies.
Price to Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median